VANI
Vivani Medical Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$88.88M
P/E Ratio
—
EPS
$-0.43
Beta
3.37
52W High
$1.92
52W Low
$0.92
50-Day MA
$1.18
200-Day MA
$1.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vivani Medical Inc.
Vivani Medical Inc. (VANI) is an innovative biotechnology firm committed to transforming the management of chronic diseases through its proprietary drug delivery systems. The company specializes in biocompatible implants that facilitate sustained medication release, addressing significant health challenges, particularly in diabetes and neurological conditions. With a robust product pipeline and a strong intellectual property portfolio, Vivani is poised to meet critical unmet medical needs, making it an attractive prospect for institutional investors seeking exposure in the rapidly evolving healthcare sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 130,000 |
| EBITDA | $-27.13M |
| Operating Margin | 0.00% |
| Return on Equity | -159.60% |
| Return on Assets | -42.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.21 |
| Price-to-Book | 5.60 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -3.93 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $84.65M |
| Float | $38.86M |
| % Insiders | 34.34% |
| % Institutions | 6.52% |
Historical Volatility
HV 10-Day
75.37%
HV 20-Day
73.71%
HV 30-Day
61.43%
HV 60-Day
67.20%
HV Rank
52.4%
Volatility is currently expanding
Data last updated: 4/14/2026